<SEC-DOCUMENT>0001628280-25-013572-index.html : 20250318
<SEC-HEADER>0001628280-25-013572.hdr.sgml : 20250318
<ACCEPTANCE-DATETIME>20250318173052
ACCESSION NUMBER:		0001628280-25-013572
CONFORMED SUBMISSION TYPE:	ARS
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20250318
FILED AS OF DATE:		20250318
DATE AS OF CHANGE:		20250318
EFFECTIVENESS DATE:		20250318

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CUMBERLAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001087294
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		ARS
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33637
		FILM NUMBER:		25749781

	BUSINESS ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE,
		STATE:			TN
		ZIP:			37203
		BUSINESS PHONE:		615-255-0068

	MAIL ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203
</SEC-HEADER>
<DOCUMENT>
<TYPE>ARS
<SEQUENCE>1
<FILENAME>cmb25-0380142024annualrepo.pdf
<DESCRIPTION>ARS
<TEXT>
Document 1 - file: cmb25-0380142024annualrepo.pdf

</DOCUMENT>
</SEC-DOCUMENT>